2 December 2021 - potential offer
Clinigen, the AIM-listed global pharmaceutical services and products company, has announced that it is in talks about a potential takeover of the company by Triton Investment Management Ltd. These talks are at an advanced stage although there is no certainty that an offer will be made. The company has advised shareholders to take no action and we agree with this and recommend readers who hold the shares to hang on. We will retain our holding within the Trader portfolio for the time being. HOLD
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.
